Update on management of advanced melanoma: We’ve come a long way
A topline look at a complex topic Hensin Tsao, MD, PhD, with Cheryl Guttman Krader Management for patients with advanced melanoma has changed dramatically over the past decade with an expanding armamentarium of medical therapies approved for the treatment of unresectable disease or as adjuvant therapy following primary tumor resection (Table). Such a rapid revolution […]